Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REFRESH CELLUVISC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TISLELIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TIMOLOL MALEATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ATORVASTATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VICTOZA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REVLIMID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TISLELIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VIGAFYDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BLINATUMOMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SEMAGLUTIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUVYZAT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KEYTRUDA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TISLELIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TALVEY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ASFOTASE ALFA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYCLARYS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NOVORAPID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OSIMERTINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TEZEPELUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SELUMETINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SEMAGLUTIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUVYZAT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KESIMPTA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VIGAFYDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TISLELIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BRUKINSA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LIDOCAINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SIMPONI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology